These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2903923

  • 1. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB.
    J Rheumatol Suppl; 1988 Sep; 16():14-6. PubMed ID: 2903923
    [Abstract] [Full Text] [Related]

  • 2. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V.
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [Abstract] [Full Text] [Related]

  • 3. Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia.
    Gremse DA, Bancroft J, Moyer MS.
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):261-3. PubMed ID: 2572687
    [Abstract] [Full Text] [Related]

  • 4. Desensitization to sulfasalazine.
    Hessemer CA, Schinagl EF.
    Am J Gastroenterol; 1993 Mar; 88(3):460-1, 462. PubMed ID: 8094941
    [No Abstract] [Full Text] [Related]

  • 5. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI, Present DH, Rubin PH, Fochios SE.
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [Abstract] [Full Text] [Related]

  • 6. [Adverse effects of sulfasalazine: discussion of mechanism and role of sulfonamide structure].
    Atheymen R, Affes H, Ksouda K, Mnif L, Sahnoun Z, Tahri N, Zeghal KM, Hammami S.
    Therapie; 2013 Feb; 68(6):369-73. PubMed ID: 24356188
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT.
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [Abstract] [Full Text] [Related]

  • 8. Azathioprine in inflammatory bowel disease, a safe alternative?
    Tanis AA.
    Mediators Inflamm; 1998 May; 7(3):141-4. PubMed ID: 9705598
    [Abstract] [Full Text] [Related]

  • 9. Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
    Halmos B, Anastopoulos HT, Schnipper LE, Ballesteros E.
    Ann Hematol; 2004 Apr; 83(4):242-6. PubMed ID: 13680174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.
    Rubin R.
    Am J Gastroenterol; 1994 May; 89(5):789-91. PubMed ID: 7909645
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 13. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
    Zwillich SH, Comer SS, Lee E, Erdman WA, Lipsky PE.
    J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
    [Abstract] [Full Text] [Related]

  • 14. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL, Ghezail M, Chertok P, Blotman F.
    Clin Exp Rheumatol; 1992 Sep; 10(4):427. PubMed ID: 1356682
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of juvenile spondyloarthropathies with sulfasalazine].
    Job-Deslandre C, Menkès CJ.
    Rev Rhum Ed Fr; 1993 Sep; 60(7-8):489-91. PubMed ID: 7908584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A, Pedone V, Lamanna G, Cervini C.
    Clin Ter; 1997 Sep; 148(1-2):7-13. PubMed ID: 9377840
    [Abstract] [Full Text] [Related]

  • 19. Desensitization for sulfasalazine skin rash.
    Purdy BH, Philips DM, Summers RW.
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.